Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander?

Sung Soo Ahn, Jang Woo Ha, Yong Beom Park, Sang Won Lee

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Objective: To investigate the significance of RF positivity in ANCA-associated vasculitis (AAV) patients. Methods: AAV patients were divided into groups as follows: RF (+)/ANCA (+) (n = 94), RF (-)/ANCA (+) (n = 80), RF (+)/ANCA (-) (n = 15) and RF (-)/ANCA (-) (n = 25). Their clinical data, organ involvement patterns, laboratory data, and patient outcomes were assessed. Kaplan-Meier analysis and propensity score matching (PSM) were performed to compare outcomes and analyse differences between the groups. Results: Of the 214 patients, RF and ANCA positivity was found in 109 (50.9%) and 174 (81.3%) patients, respectively. RF (+)/ANCA (+) patients more frequently presented with general manifestations (58.5%) than the other groups. Additionally, compared with those of RF (-)/ANCA (+) group, RF (+)/ANCA (+) patients were older, had higher white blood cell, neutrophil, platelet counts and acute phase reactants; however, creatinine and albumin levels were lower. The end-stage kidney disease-free survival rate was significantly higher in the RF (+)/ANCA (+) group (P =0.013), while the proportion of renal involvement was comparable to the RF (-)/ANCA (+) group. PSM showed no difference in patient outcomes between the two groups after adjustment. Conclusion: RF positivity was associated with a distinct phenotype in AAV patients. In particular, difference was observed in clinical features and outcomes between RF (+)/ANCA (+) and RF (-)/ANCA (+) groups, although the direct prognostic implication of RF was not evident.

Original languageEnglish
Pages (from-to)1366-1375
Number of pages10
JournalRheumatology (United Kingdom)
Volume61
Issue number4
DOIs
Publication statusPublished - 2022 Apr 1

Bibliographical note

Funding Information:
This work was supported by a faculty research grant from Yonsei University College of Medicine (6-2019-0184)

Publisher Copyright:
© 2021 The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

All Science Journal Classification (ASJC) codes

  • Rheumatology
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander?'. Together they form a unique fingerprint.

Cite this